Degarelix0 vendors competing
No vendor pricing available for this peptide yet.
Research details
Degarelix — research data
Regulatory statusFDA-approved (Firmagon)
NCAA D1Banned
Overview
About Degarelix
Mechanism of action
GnRH receptor antagonist; immediate testosterone castration without initial testosterone flare
Safety profile
Injection site reactions, hot flashes, weight gain · Approved for prostate cancer; injection site reactions common but manageable
Related pages